Organophosphorus pesticides are widely used as insecticides in agriculture both in developed and developing countries in spite of reported potential toxicity. They induce neurotoxic effects either upon acute or chronic exposure. It was found previously that zinc (Zn) supplementation exerted a neuroprotective effect against organophosphorus pesticide-induced neurodegenerative disorders in experimental animals. This study therefore, aimed to investigate the possible association between serum zinc level and organophosphorus-induced delayed polyneuropathy. Fifty acute organophosphorus poisoned cases admitted to Zagazig University Hospitals from February to August 2016 were enrolled in this study. Another Forty six healthy individuals (age-and sex-matched) served as a control group. Both groups were investigated for serum lipid peroxidation product (malondialdehyde: MDA) and total antioxidant capacity (TAC) levels as well as lymphocytic neuropathy target esterase (NTE) and plasma acetylcholinesterase (AChE). Then, they were followed up for 4 weeks to assess the development of delayed polyneuropathy (diagnosed clinically and confirmed by motor and sensory conduction studies). Serum levels of Zn, MDA and TAC as well as lymphocytic NTE and plasma AChE were measured for those developed organophosphorus delayed polyneuropathy. Organophosphorus intoxication has resulted in a significant elevation in the levels of MDA, suggesting oxidative stress. On the other hand, TAC levels as well as measured lymphocytic NTE and plasma AChE activities were found to be significantly reduced in the intoxicated group. However, at the end of the follow up period, 7 cases developed delayed polyneuropathy; 5 of them were Zn deficient while the rest were with normal Zn level. Cases with delayed polyneuropthy showed also a significant increase in lipid peroxidation along with impairment of estrases activities compared to cases on admission. Furthermore, serum Zn level showed a significant positive correlation with TAC, AChE, NTE and a negative correlation with MDA, where serum zinc level seems to be the strongest determinants for the prediction of delayed polyneuropathy. Thus, we conclude that Zn deficiency has a potential role in organophosphorusinduced delayed polyneuropathy. This may be due to its involvement in the activity of antioxidant enzymes. However, further future large scale studies are needed to clarify the exact mechanism by which Zn deficiency mediated neurotoxicity upon organophosphorus induced polyneuropathy.
INTRODUCTION
Organophosphorus-induced delayed polyneuropathy (OPIDN) is a rare toxicity resulted from exposure to certain organophosphorus (OP) pesticides. It is characterized by distal axonal degeneration of both the peripheral and central nervous systems. It is commonly occurring 1-4 weeks after acute toxicity ( Lower extremity paresthesias may appear with a "stocking-glove" distribution and progress to weakness, ataxia, depression of deep tendon reflexes, and paralysis with occasional progression to the arms and hands (Chatterjee and Sharma, 2003). Human and experimental data indicate that recovery is usually complete in young patients. The electrophysiological changes include reduced amplitude of the compound muscle potential, increased distal latencies and normal or slightly reduced nerve conduction velocities. The progression of the disease, usually over a few days, may lead to non-excitability of the nerve with electromyographical signs of denervation. Nerve biopsies have been performed in a few cases and showed axonal degeneration with secondary demyelination (Nand et al., 2007).
Neuropathy target esterase (NTE) is thought to be the target of OPIDN initiation. The ratio of inhibitory powers for acetylcholinesterase (AChE) and NTE represents the crucial mark for the development of OP-induced peripheral neuropathy and its etiology. Animal studies revealed that OP insecticides with cholinergic toxicity like chlorpyrifos, dichlorvos, isofenphos, methamidophos, mipafox, trichlorfon, trichlornat, phosphamidon/mevinphos and by certain carbamates, have much higher potential to result in OPIDN (Sogorb et al., 2016). Zinc (Zn), a key constituent of more than 300 mammalian enzymes and many transcription factors has proved its protective potential in various models of animal pesticides toxicity. Zn has been proven to have hepato-protective potential against chlorpyrifos toxicity (Malhotra and Dhawan, 2014). This study therefore, aimed to investigate the possible association between serum Zn level and organophosphorus -induced delayed polyneuropathy. -4 M of Sbutyrylthiocholine iodide (substrate) were pre-incubated at 37°C for 10 min for coupling. 20 μl of plasma samples was added into each tube of the aforementioned substrate solution. The mixture was vortexed and absorbances of produced yellow colour were read spectrophotometrically at 1 min interval for 3 min at 412 nm. Blank was run parallel to each sample without addition of substrate. Activity was expressed as U/l.
SUBJECTS & METHODS

STUDY POPULATION
Lymphocytes were isolated by centrifuging in a Ficoll-Verografin density gradient. Lymphocytic NTE activity was measured according to the method of Johnson (1977) by a reaction depends on the enzymatic cleavage of phenylvalerate to phenol, which is subjected to a colour reaction that can be measured spectrophotometrically. 50 µl of the lymphocytic suspension was pipetted into a plastic tube. The tube was filled with deionised water to 5 ml and allowed to stand for 5 min. 1 ml of the lymphocytic haemolysate was filled into 4 sealable test-tubes with a capacity of (2 sample blanks and 2 samples). Samples were incubated with 0.5 Tris EDTA buffer, 0.5 ml of 2 organophosphates, paraoxon and mipafox working solutions at 37 o C for 20 min in shaking bath. The reaction mixture was further incubated with 2 ml stop I and 2 ml substrate solutions at 37 o C for 60 min in shaking bath and then with 2 ml stop I and 2 ml colour solutions at room temperature for 15 min. The absolute NTE activity was calculated from the difference between the phenylvalerate concentrations in the lymphocyte samples containing only paraoxon and in those samples containing also mipafox. Finally, absorbance was determined at 492 nm using deionised water as a blank. The absorbance of samples was read in duplicate.
Zinc (Zn) concentration was determined in 1 ml serum sample after digestion for 24 h with conc nitric acid and hydrochloric acid (5:1) (Luterotti et al., 2015). Samples were then filtered, diluted with deionized water and analyzed for Zn using atomic absorption flame emission spectrophotometery at wavelength 213.9 nm.
Serum malondialdehyde (MDA was determined by measuring thiobarbituric reactive species using the method of Yagi (1998) in which the thiobarbituric acid-reactive substances react with thiobarbituric acid to produce a red colored complex with peak absorbance at 532 nm.
Serum total antioxidant capacity (TAC) was determined using commercially available kit (Biodiagnostic, Dokki, Giza, Egypt) When correlation was done between serum Zn level and other tested parameters there was a significant positive correlation with TAC, AChE, NTE and a negative correlation with MDA (p<0.001). When we introduce all significant variables to multiple regression analysis (the model), the variables that persisted significant (the strongest significant) in the model was serum Zn level. Therefore, serum Zn level seems to be significant determinant factors for the prediction of delayed polyneuropthy (Tables 4&5, Fig 2) . These results support our work where we found a significant increase in MDA level, as a biomarker for lipid peroxidation, and a significant decrease In TAC in OP intoxicated subjects when compared with control group were detected.
RESULTS
A -Admission Results
The inhibition in the activity of lymphocytic NTE in the current study made our cases at a high risk for developing OPIDN. suggested that the initial mechanism associated with development of OPIDN is phosphorylation and subsequent aging of NTE enzyme. These events lead to progressive deficit of retrograde axonal transport in the nervous system. Moreover, the current study included moderate to severe poisoned cases and those with delayed presentation that make them at higher risk for developing OPIDN. It is well established that the risk for esterases enzyme aging is more likely in severe cases and in late presenters
Clothier and Johnson (1980).
In the present study, cases developed OPIDN have mixed sensory motor polyneuropathy with predominating motor affection. OPIDN begins with sensory loss in hands and feet, but exclusively sensory neuropathy is not a feature in humans. Motor alterations such as slowed conduction and, eventually, bilateral and symmetrical weakness progressing to flaccidity of the lower and upper extremities were described in the literature (Gallo and Lawryk, 1991 & Ecobichon, 1994).
Moreover, cases developed OPIDN in the present study showed a significant decrease in NTE with significant improvement of plasma AChE and oxidative stress indicators (MDA, TAC). In addition, Pomeroy-Black et al. (2007) stated that elucidation of the pathophysiology and mechanism of OPIDN, as well as the assessment of OP compounds for their neuropathic potential, has been hampered by a lack of knowledge concerning the physiological function of NTE and deficiencies in available models, either in vivo or in vitro.
A previous study showed that Zn supplementation to chlorpyrifos-treated animals nearly normalized lipid peroxidation and induced free radical generation in cerebrum. This was associated with a significant improvement in the levels of antioxidants including reduced glutathione, and GST enzymatic activity of in both cerebrum as well as cerebellum alnong with improvement was in the behavior of chlorpyrifos-treated animals upon Zn supplementation. Therefore, Zn seems to have a potential to act as a neuroprotectant against pesticide-induced neurodegenerative and behavioral disorders (Malhotra et al., 2011) . Such neuroprotective effect of Zn could be attributed to being a cofactor in several antioxidant enzymes. Zn is an essential trace element that regulates a large number of metabolic processes in the brain (Singla and Dhawan, 2017). It is one of the most abundant essential minerals. It is present in the structure of many proteins, like enzymes and transcription factors and modulates the function of other proteins, including receptors, enzymes and proteins involved in cell signalling. Zinc is a key micronutrient in the physiology of the nervous system, participating in the modulation of synaptic transmission, regulation of neuronal cell oxidant production, regulation of signalling cascades, neural cell proliferation, cell survival, and neuronal differentiation (Adamo and Oteiza, 2010).
These studies along with studies questioned the role of NTE in OPIDN make the rational for us to investigate the role of Zn in development of delayed polyneuropathy in our cases. Moreover, using lymphocyte NTE in humans as a biomarker of OPIDN has many restrictions.
Lymphocytes are heterogeneous, have variability in the expression of NTE and not well correlated with inhibition of central NTE activity (lotti et al., 1984) and it is not available in clinical labs of hospitals to be ordered routinely. However, serum zinc level is cheap and available in many clinical laboratories and can be used as a biomarker for prediction of OPIDN.
Serum zinc levels of our cases with OPIDN revealed a significant decrease when compared with controls. Furthermore, there was a positive correlation between seum Zn level and NTE and TAC. Serum Zn level was negatively correlated with MDA. Moreover Zinc was found to be the strongest determinant factor for the prediction of delayed polyneuropathy.
The essential role of zinc is demonstrated by the deleterious effects of zinc deficiency and by the link between zinc regulatory dysfunction and the pathophysiology of various disease states, including neurodegeneration. Zinc acts as a cofactor for an estimated 3,000 human proteins, representing 10% of the genome, and has a well-established role in regulation of gene expression through metalresponsive transcription-factor-1 (MTF1) genome, and has a wellestablished role in regulation of gene expression through metalresponsive transcription-factor-1 (MTF1) (Taylor et  al., 2012) . Also, Zinc is an integral part of the transcription factor Miz1 (Mycinteracting zinc finger 1) which is a known regulator of the cell functions in the peripheral nervous system. (Franco et al., 2009 ). These results can explain the strong correlation found in our study between deficiency of serum zinc level and oxidative stress marker.
CONCLUSION
Thus, we conclude that Zn deficiency has a potential role in organophosphorus induced delayed polyneuropathy. This may be due to its involvement in the activity of antioxidant and esterases enzymes.
RECOMMENDATIONS
In the light of the current results, it is recommended to add zinc supplements to treatment regimes of organophosphorus poisoning especially those having zinc deficiency on admission. Also, further future large scale studies are needed to clarify the exact mechanism by which Zn deficiency mediated neurotoxicity upon organophosphorus induced polyneuropathy.
